Efficacy of Combining Pasireotide With Aspiration Sclerotherapy to Improve Volume Reduction of Hepatic Cysts (Sclerocyst)

Clinical Trial ID NCT02048319

PubWeight™ 0.75‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02048319

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Aspiration sclerotherapy combined with pasireotide to improve reduction of large symptomatic hepatic cysts (SCLEROCYST): study protocol for a randomized controlled trial. Trials 2015 0.75
Next 100